CAP was implied to attenuate cardiac apoptosis and hypertrophy induced by TAC, which could be attributed to the inhibition of the Wnt3a/β‐catenin and the JAK2/STAT3 signalling pathway, respectively.7 The gene discussed is STAT3; the disease is persistent truncus arteriosus.